Tailored Treatment: Customizable dosing adapts to your individual needs, ensuring a personalized approach to your health journey
Date of First FDA Approval: October 21, 2019 Indications Trikafta Is FDA-approved for: Cystic fibrosis (CF) WAC of Trikafta: $311,741 per year Why It Sold So Well: Trikafta is approved for the treatment of CF in patients aged two years and older who have at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive based on in vitro data
Returning Patients simply text your Doctor directly or book the appointment type of your choice
Compounded semaglutide is a GLP-1 medication used for chronic weight management
It requires sterile technique, causes discomfort for needle-averse individuals, creates potential injection site reactions, and demands careful rotation to avoid tissue damage over extended protocols
GMP & MADE IN THE USA - We use only the finest ingredients, all of which are manufactured in our US, GMP compliant, state-of-the-art, facility